Harpoon Therapeutics, Inc. Common Stock
HARP
HARP was delisted on the 8th of March, 2024.
88 hedge funds and large institutions have $562M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 12 closing their positions.
94% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 18
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
70% more capital invested
Capital invested by funds: $330M → $562M (+$232M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
14% more funds holding
Funds holding: 77 → 88 (+11)
4.55% more ownership
Funds ownership: 78.39% → 82.95% (+4.6%)
31% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$31.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$21.5M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$12.6M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$25.8M |
| 2 |
Millennium Management
New York
|
-$3.07M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.77M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.66M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.19M |
HARP Hedge Fund Activity: Q1 2021 in Review
88 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2021, worth a combined $562M — up 70% from $330M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new HARP positions and 12 closed out — a net gain of 11 holders — while 35 added to existing stakes and 18 trimmed.
The largest buyer was Aquilo Capital Management, opening a new position worth an estimated $31.2M. The largest seller was MPM Asset Management, cutting an estimated $25.8M.
- 88 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2021, up from 77 in Q4 2020.
- Funds reported $562M of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2021, up 70% quarter-over-quarter.
- 23 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2021 and 12 closed out, a net change of +11 holders.
- The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q1 2021 was Aquilo Capital Management, an estimated $31.2M added.
- The largest Harpoon Therapeutics, Inc. Common Stock seller in Q1 2021 was MPM Asset Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q1 2021.